||EPS - Basic
||Market Cap (m)
|Household Goods & Home Construction
Accrol Gp Share Discussion Threads
Showing 26 to 48 of 50 messages
|Dipped my toe here.Boring but solid growth ahead.
I could be accused of bottom fishing but that is not the case here :o)|
|CEO spent £130k on shares - nice vote of confidence. Price action looking very good IMO|
|RNS increasing capacity with new premises in anticipation of growing orders from both discounters and majors. Unfussy confident communicators I like these.|
|No dividends to be paid this side of year end April 2017 MrMark01.|
|good loo rolls too. picked up a pack of 9 from b&m for £2
no tripple velvet, but means the mrs doesn't use half a roll every time to makes a visit ;)|
|boring old share, just keeps going up... making profits and paying divi's...
boring boring boring...|
|Breaking out to a new high.|
|Thanks - just discovered that myself ! Much better|
|The majority of debt is being paid off by the £60m+ from the recent listing. Ratio should be more like 1x to 1.5x at year end.|
|I like the story, but the thing that caught my eye was debt which is 4x profits which seems a bit high. Anyone any views on this?|
|Investor's Chronicle still have this as a buy.|
|From the equity development note:
"Although Accrol sources its parent reels from overseas suppliers, both it and UK mills are both subject to relatively similar forex exposure risk. Around 70% of the cost of producing a parent reel is pulp and a similar proportion of the cost of Accrol’s finished goods is tissue, both generally traded in USD. In order to hedge this risk operationally Accrol’s sources via a smaller number of mills and typically, takes over 50% of their output. That provides it with some scope to use its leverage with suppliers to push down the USD/tonne rate to protect its margins."
In other words, Brexit may cause some major short term margin pressure on the business once their current hedges expire. With most their costs of material in USD and the large movement since Brexit, they are going to have to push price increases through to 'discount' chain customers.
This is easier said than done in my experience and may have a material impact on future profitability.|
|and today all buys at 114.9p....but showing as sells|
|joined in this morning. all buys at 115p|
|ED have updated their note, no target price but PER 10 with 5% divi well covered seems good value.
|Good set of results, surprised there's no movement.|
|Up you go...
Maiden results out 22nd July. GLA|
|Big dirty small cap spread though...|
|Yep - has the makings of a good long term hold. 6% divi...|
nice contract win and positive trading update.
In the event that there is a period of reduced consumer expenditure following the UK's decision to leave the European Union, it is possible that the move towards non-discretionary economy and private label products will accelerate. If this happens, Accrol believes it is well positioned to benefit as over 50% of sales are generated from the discount market segment and the Company is primarily focused on supplying private label products to both discount and multiple retailers.
The Company remains significantly hedged against adverse currency movements for the financial year ending 30 April 2017. Moreover, whilst only two months of this financial year have passed, the directors are comfortable with market forecasts and continue to see opportunities in the market. Results for the year ended 30 April 2016 will be announced on 22 July 2016.|
|Majedie’s Citywire AA-rated UK equity team have torn a few sheets off the recent £90 million Alternative Investment Market flotation of tissue manufacturer Accrol Group (ACRL).
20th June 2016
|And there's a detailed 15 page Equity Development note. I downloaded it from Research Tree but you can also get it direct from Equity Development I think...
The front page is already pasted above but the full note well worth a read.|
|A pre-IPO investor cashed out 500,000 shares @110p after the open this morning.